Literature DB >> 20865351

Mitochondrial dysfunction and oxidative damage to sarcomeric proteins.

Marina Bayeva1, Hossein Ardehali.   

Abstract

Hypertension is an important risk factor for the development of heart failure. Increased production of reactive oxygen species (ROS) contributes to cardiac dysfunction by activating numerous pro-hypertrophic signaling cascades and damaging the mitochondria, thus setting off a vicious cycle of ROS generation. The way in which oxidative stress leads to exacerbation of systolic and diastolic dysfunction is still unclear, however. In skeletal muscle and ischemic myocardium, increased ROS production causes preferential oxidation of myofibrillar proteins and provides a mechanistic link between oxidative damage and impaired contractility through disruption of actin-myosin interactions, enzymatic functions, calcium sensitivity, and efficiency of cross-bridge cycling. In this review, we summarize recent findings in the fields of heart failure and sarcomere biology and speculate that oxidative damage to myofibrils may contribute to the development of heart failure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865351     DOI: 10.1007/s11906-010-0149-8

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  53 in total

1.  Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice.

Authors:  Jennifer K Bendall; Alison C Cave; Christophe Heymes; Nicholas Gall; Ajay M Shah
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

Review 2.  Redox signaling in hypertension.

Authors:  Tamara M Paravicini; Rhian M Touyz
Journal:  Cardiovasc Res       Date:  2006-05-09       Impact factor: 10.787

3.  Myofibrillar protein oxidation and contractile dysfunction in hyperthyroid rat diaphragm.

Authors:  Takashi Yamada; Takaaki Mishima; Makoto Sakamoto; Minako Sugiyama; Satoshi Matsunaga; Masanobu Wada
Journal:  J Appl Physiol (1985)       Date:  2007-02-15

4.  Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies.

Authors:  Jaime M Predmore; Ping Wang; Frank Davis; Sarah Bartolone; Margaret V Westfall; David B Dyke; Francis Pagani; Saul R Powell; Sharlene M Day
Journal:  Circulation       Date:  2010-02-16       Impact factor: 29.690

5.  Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure.

Authors:  A van der Laarse
Journal:  Cardiovasc Res       Date:  2002-10       Impact factor: 10.787

Review 6.  Genetic determinants of cardiac hypertrophy.

Authors:  Ali J Marian
Journal:  Curr Opin Cardiol       Date:  2008-05       Impact factor: 2.161

7.  Possible involvement of mitochondrial energy-producing ability in the development of right ventricular failure in monocrotaline-induced pulmonary hypertensive rats.

Authors:  Takuya Daicho; Tatsuya Yagi; Yohei Abe; Meiko Ohara; Tetsuro Marunouchi; Satoshi Takeo; Kouichi Tanonaka
Journal:  J Pharmacol Sci       Date:  2009-09       Impact factor: 3.337

8.  Functional, structural, and chemical changes in myosin associated with hydrogen peroxide treatment of skeletal muscle fibers.

Authors:  Ewa Prochniewicz; Dawn A Lowe; Daniel J Spakowicz; LeeAnn Higgins; Kate O'Conor; LaDora V Thompson; Deborah A Ferrington; David D Thomas
Journal:  Am J Physiol Cell Physiol       Date:  2007-11-14       Impact factor: 4.249

9.  Modifications of myosin-regulatory light chain correlate with function of stunned myocardium.

Authors:  Melanie Y White; Stuart J Cordwell; Hugh C K McCarron; Adrian S Tchen; Brett D Hambly; Richmond W Jeremy
Journal:  J Mol Cell Cardiol       Date:  2003-07       Impact factor: 5.000

10.  Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats.

Authors:  Takashi Yamada; Kohzo Nagata; Xian Wu Cheng; Koji Obata; Masako Saka; Masaaki Miyachi; Keiko Naruse; Takao Nishizawa; Akiko Noda; Hideo Izawa; Masafumi Kuzuya; Kenji Okumura; Toyoaki Murohara; Mitsuhiro Yokota
Journal:  Eur J Pharmacol       Date:  2009-06-06       Impact factor: 4.432

View more
  28 in total

1.  Xanthine oxidase inhibition preserves left ventricular systolic but not diastolic function in cardiac volume overload.

Authors:  James D Gladden; Blake R Zelickson; Jason L Guichard; Mustafa I Ahmed; Danielle M Yancey; Scott Ballinger; Mayilvahanan Shanmugam; Gopal J Babu; Michelle S Johnson; Victor Darley-Usmar; Louis J Dell'Italia
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-06       Impact factor: 4.733

Review 2.  Mitochondria and cardiovascular diseases-from pathophysiology to treatment.

Authors:  Gerasimos Siasos; Vasiliki Tsigkou; Marinos Kosmopoulos; Dimosthenis Theodosiadis; Spyridon Simantiris; Nikoletta Maria Tagkou; Athina Tsimpiktsioglou; Panagiota K Stampouloglou; Evangelos Oikonomou; Konstantinos Mourouzis; Anastasios Philippou; Manolis Vavuranakis; Christodoulos Stefanadis; Dimitris Tousoulis; Athanasios G Papavassiliou
Journal:  Ann Transl Med       Date:  2018-06

3.  Inhibiting mitochondrial Na+/Ca2+ exchange prevents sudden death in a Guinea pig model of heart failure.

Authors:  Ting Liu; Eiki Takimoto; Veronica L Dimaano; Deeptankar DeMazumder; Sarah Kettlewell; Godfrey Smith; Agnieszka Sidor; Theodore P Abraham; Brian O'Rourke
Journal:  Circ Res       Date:  2014-04-29       Impact factor: 17.367

Review 4.  Maladaptive modifications in myofilament proteins and triggers in the progression to heart failure and sudden death.

Authors:  Sumeyye Yar; Michelle M Monasky; R John Solaro
Journal:  Pflugers Arch       Date:  2014-02-01       Impact factor: 3.657

5.  Functional proteomic analysis reveals sex-dependent differences in structural and energy-producing myocardial proteins in rat model of alcoholic cardiomyopathy.

Authors:  Rachel L Fogle; Christopher S Hollenbeak; Bruce A Stanley; Thomas C Vary; Scot R Kimball; Christopher J Lynch
Journal:  Physiol Genomics       Date:  2011-01-18       Impact factor: 3.107

Review 6.  Drug-induced mitochondrial dysfunction and cardiotoxicity.

Authors:  Zoltán V Varga; Peter Ferdinandy; Lucas Liaudet; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

Review 7.  Mitochondria as a therapeutic target in heart failure.

Authors:  Marina Bayeva; Mihai Gheorghiade; Hossein Ardehali
Journal:  J Am Coll Cardiol       Date:  2012-12-05       Impact factor: 24.094

Review 8.  Physiological and pathophysiological reactive oxygen species as probed by EPR spectroscopy: the underutilized research window on muscle ageing.

Authors:  Engy A Abdel-Rahman; Ali M Mahmoud; Abdulrahman M Khalifa; Sameh S Ali
Journal:  J Physiol       Date:  2016-03-17       Impact factor: 5.182

Review 9.  Pyruvate enhancement of cardiac performance: Cellular mechanisms and clinical application.

Authors:  Robert T Mallet; Albert H Olivencia-Yurvati; Rolf Bünger
Journal:  Exp Biol Med (Maywood)       Date:  2017-11-20

10.  Loss of NHE1 activity leads to reduced oxidative stress in heart and mitigates high-fat diet-induced myocardial stress.

Authors:  Vikram Prasad; John N Lorenz; Marian L Miller; Kanimozhi Vairamani; Michelle L Nieman; Yigang Wang; Gary E Shull
Journal:  J Mol Cell Cardiol       Date:  2013-09-29       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.